BIOCON - Biocon | Wealthrox

Biocon

BIOCON · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar-Shaw · MD: Siddharth Mittal · Listing date: April 8, 2004 · Employees: 13500 · Bangalore · http://www.biocon.com

Stock Price vs Company Growth

0.5%

2.4%

8.9%

5.3%

0.9%

7.7%

2.2%

10y

10.0%

all

14.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 392 0.5%

389

447

Company Overview

Sales

17,321 Cr

Growth: 8.1%

Profit after Tax

495 Cr

Growth: 28.4%

Large Cap

63,827 Cr

P/E: 116.3x

Industry P/E: 34.2x

Fundamentals

Sales (Cr)	₹ 17,321
Growth	8.1%
EBITDA	20.4%
P/S	3.7x
Dividend	0.1%
P/E	116.3x
Book Value	₹ 210
PEG Ratio	14.6x
ROE	1.8%
P/B	1.9x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India (Lic)

4.11 %

Ahan- I Ltd

1.66 %

Qualified Institutional Buyer

0.61 %

Promoters

Kiran Mazumdar Shaw

39.62 %

Glentec International

19.76 %

John Mccallum Marshall Shaw

0.7 %

Ravi Rasendra Mazumdar

0.4 %

Yamini R Mazumdar

0.11 %

Others

Arun Suresh Chandavarkar

1.1 %

Beneficial Holdings Under Mgt-4

0.46 %

Iepf

0.01 %

Increase Decrease No change

Company Profile Detailed

The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe.

Belongs to (41 Indices) view more

Investors (412)

mahesh.g...

syed.sal...

vedavyas...

Followers (42)

kiran198...

deepak

nitin2